Radiology Software For Opportunistic Evaluation Of Low Bone Mineral Density
FDA product code SAO · 2 cleared devices
- Regulation
- 21 CFR 892.1171
- Review panel
- RA
- Implant
- No
- Life sustaining
- No
- Third party review
- No
- GMP exempt
- No
- Clearance span
- 2025-09-02 – 2026-06-10
This device is software which opportunistically assesses radiological images to estimate bone mineral density (BMD) intended to assist in a healthcare professional's decision to evaluate patients for possible low BMD within a bone health screening program. The software employs an algorithm that estimates BMD using eligible radiological image data obtained for other clinical purposes.
OsteoSight™ Hip (v1)
View details →No matching devices.